DE602004027362D1 - Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320 - Google Patents
Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320Info
- Publication number
- DE602004027362D1 DE602004027362D1 DE602004027362T DE602004027362T DE602004027362D1 DE 602004027362 D1 DE602004027362 D1 DE 602004027362D1 DE 602004027362 T DE602004027362 T DE 602004027362T DE 602004027362 T DE602004027362 T DE 602004027362T DE 602004027362 D1 DE602004027362 D1 DE 602004027362D1
- Authority
- DE
- Germany
- Prior art keywords
- respiratory syncytial
- syncytial virus
- compositions
- stamm
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 241000725643 Respiratory syncytial virus Species 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 241000711920 Human orthopneumovirus Species 0.000 abstract 1
- 108010088716 attachment protein G Proteins 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45833103P | 2003-03-28 | 2003-03-28 | |
| US50832003P | 2003-10-03 | 2003-10-03 | |
| PCT/US2004/009438 WO2004087062A2 (en) | 2003-03-28 | 2004-03-26 | Compositions and methods involving respiratory syncytial virus subgroup b strain 9320 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004027362D1 true DE602004027362D1 (de) | 2010-07-08 |
Family
ID=33135096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004027362T Expired - Lifetime DE602004027362D1 (de) | 2003-03-28 | 2004-03-26 | Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7572904B2 (de) |
| EP (1) | EP1613345B1 (de) |
| JP (1) | JP4783726B2 (de) |
| AT (1) | ATE469170T1 (de) |
| AU (1) | AU2004226369A1 (de) |
| CA (1) | CA2520671C (de) |
| DE (1) | DE602004027362D1 (de) |
| WO (1) | WO2004087062A2 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050176130A1 (en) * | 2002-09-27 | 2005-08-11 | Medimmune Vaccines, Inc. | Functional mutations in respiratory syncytial virus |
| CA2520671C (en) * | 2003-03-28 | 2014-03-18 | Medimmune Vaccines, Inc. | Compositions and methods involving respiratory syncytial virus subgroup b strain 9320 |
| FR2885139B1 (fr) * | 2005-04-29 | 2010-12-24 | Agronomique Inst Nat Rech | Preparation de complexes solubles proteine n-proteine p tronquee ou de proteine n soluble d'un virus de la famille des paramyxoviridae et leurs utilisations vaccinales |
| CN101384733A (zh) * | 2006-02-13 | 2009-03-11 | 奥尔加·奥尔纳茨基 | 通过元素分析实施的基因表达检测 |
| KR20080113223A (ko) * | 2006-03-06 | 2008-12-29 | 심포젠 에이/에스 | 호흡기세포 융합 바이러스 감염 치료용 재조합 폴리클로날 항체 |
| FR2899902B1 (fr) * | 2006-04-18 | 2012-01-27 | Agronomique Inst Nat Rech | Proteines de fusion proteine n d'un virus de la famille des paramyxoviridae-proteine d'interet et leurs utilisations pour la vaccination et la vectorisation intra-cellulaire. |
| KR20090127341A (ko) * | 2007-03-06 | 2009-12-10 | 심포젠 에이/에스 | 호흡기세포 융합 바이러스 감염 치료용 재조합 항체 |
| US20090017517A1 (en) * | 2007-07-13 | 2009-01-15 | Medimmune, Llc | Preparation of Negative-Stranded RNA Viruses by Electroporation |
| US8354230B2 (en) | 2007-12-21 | 2013-01-15 | Quest Diagnostics Investments Inc. | Multiplex detection assay for influenza and RSV viruses |
| JP5016731B2 (ja) * | 2008-11-05 | 2012-09-05 | メルク・シャープ・エンド・ドーム・コーポレイション | 生弱毒化呼吸器合胞体ウイルス |
| GB201019240D0 (en) | 2010-11-15 | 2010-12-29 | Vib Vzw | Respiratory syncytical virus vaccine |
| US10227569B2 (en) * | 2011-04-12 | 2019-03-12 | Emory University | Respiratory syncytial virus expression vectors |
| EP3798310A1 (de) | 2013-03-14 | 2021-03-31 | Emory University | Rekombinante rsv mit stillen mutationen, impfstoffe und zugehörige verfahren |
| KR20180085730A (ko) | 2015-10-29 | 2018-07-27 | 에모리 유니버시티 | 키메라 rsv, 면역원성 조성물, 및 사용 방법 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4800078A (en) * | 1987-05-28 | 1989-01-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb |
| US5840520A (en) * | 1989-08-28 | 1998-11-24 | Aviron | Recombinant negative strand RNA virus expression systems |
| GB9200117D0 (en) * | 1992-01-06 | 1992-02-26 | Connaught Lab | Production of recombinant chimeric proteins for vaccine use |
| IL105456A (en) * | 1992-04-21 | 1996-12-05 | American Home Prod | Vaccines of attenuated respiratory syncytial virus |
| US20030054505A1 (en) * | 1997-09-26 | 2003-03-20 | Hong Jin | Recombinant rsv expression systems and vaccines |
| US6713066B1 (en) * | 1996-07-15 | 2004-03-30 | The United States Of America As Represented By The Department Of Health And Human Services | Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 |
| BR9712138A (pt) * | 1996-09-27 | 2000-01-18 | American Cyanamid Co | Vìrus de rna isolado, vacina, processo para imunizr um indivìduo para induzir proteção contra um vìrus de rna não segmentado, sentido negativo, de filamento único, da ordem mononegavirales e para produzir vìrus de rna, molécula de ácido nucleico isolada e composição. |
| US6017694A (en) | 1997-12-19 | 2000-01-25 | American Cyanamid Company | Methods of screening for modulators of respiratory syncytial virus matrix protein interaction |
| CN1600852A (zh) | 1998-03-26 | 2005-03-30 | 惠氏控股有限公司 | 引起麻疹病毒或人呼吸道合胞病毒亚组b减毒的突变 |
| AU3652202A (en) | 2000-11-28 | 2002-06-11 | Aviron Inc | Recombinant rsv virus expression systems and vaccines |
| HUP0500244A3 (en) * | 2001-01-19 | 2011-03-28 | Vironovative Bv | A virus causing respiratory tract illness in suspectible mammals |
| US20050176130A1 (en) | 2002-09-27 | 2005-08-11 | Medimmune Vaccines, Inc. | Functional mutations in respiratory syncytial virus |
| CA2520671C (en) * | 2003-03-28 | 2014-03-18 | Medimmune Vaccines, Inc. | Compositions and methods involving respiratory syncytial virus subgroup b strain 9320 |
-
2004
- 2004-03-26 CA CA2520671A patent/CA2520671C/en not_active Expired - Fee Related
- 2004-03-26 AT AT04749465T patent/ATE469170T1/de not_active IP Right Cessation
- 2004-03-26 DE DE602004027362T patent/DE602004027362D1/de not_active Expired - Lifetime
- 2004-03-26 AU AU2004226369A patent/AU2004226369A1/en not_active Abandoned
- 2004-03-26 EP EP04749465A patent/EP1613345B1/de not_active Expired - Lifetime
- 2004-03-26 US US10/811,508 patent/US7572904B2/en not_active Expired - Lifetime
- 2004-03-26 WO PCT/US2004/009438 patent/WO2004087062A2/en active Application Filing
- 2004-03-26 JP JP2006509391A patent/JP4783726B2/ja not_active Expired - Fee Related
-
2009
- 2009-07-23 US US12/508,075 patent/US8163530B2/en not_active Expired - Lifetime
-
2012
- 2012-04-17 US US13/449,087 patent/US20120263744A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE469170T1 (de) | 2010-06-15 |
| US8163530B2 (en) | 2012-04-24 |
| US20120263744A1 (en) | 2012-10-18 |
| WO2004087062A3 (en) | 2005-03-31 |
| CA2520671A1 (en) | 2004-10-14 |
| JP2006524053A (ja) | 2006-10-26 |
| EP1613345B1 (de) | 2010-05-26 |
| EP1613345A4 (de) | 2007-01-10 |
| US20040224309A1 (en) | 2004-11-11 |
| US7572904B2 (en) | 2009-08-11 |
| US20090285853A1 (en) | 2009-11-19 |
| CA2520671C (en) | 2014-03-18 |
| JP4783726B2 (ja) | 2011-09-28 |
| WO2004087062A2 (en) | 2004-10-14 |
| EP1613345A2 (de) | 2006-01-11 |
| AU2004226369A1 (en) | 2004-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69922958D1 (de) | Hcv hüllproteine partikel : verwendung für therapeutische impfung | |
| NL300897I2 (nl) | Neisseira meningitidis serogroep B recombinant gelipideerd fHbp subfamilie A05 eiwit | |
| CA2253636A1 (en) | Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof | |
| DE602004027362D1 (de) | Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320 | |
| WO2003086451A8 (en) | Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses | |
| DE60125381D1 (de) | Zusammensetzungen und verfahren mit analogen von g-csf | |
| AU9078401A (en) | Antimicrobial peptides and methods of use | |
| WO2000075350A3 (en) | Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use | |
| WO2002072036A3 (en) | Compositions and methods comprising west nile virus polypeptides | |
| AU6160201A (en) | Human polypeptides causing or leading to the killing of cells including lymphoidtumor cells | |
| BRPI0411363A (pt) | seqüências de ácidos nucléicos codificando e composições compreendendo peptìdeo sinal ige e/ou il-15 e processos para uso das mesmas | |
| WO2004085633A8 (en) | A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof | |
| WO2008033375A3 (en) | Long lasting drug formulations | |
| WO2004035732A3 (en) | Human polypeptides encoded by polynucleotides and methods of their use | |
| MXPA05005202A (es) | Vacuna. | |
| ATE543833T1 (de) | Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen | |
| WO2005035558A3 (en) | Piscirickettsia salmonis antigens and use thereof | |
| WO2000012535A3 (en) | Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof | |
| WO2005011571A3 (en) | Hepatitis virus core proteins as vaccine platforms and methods of use thereof | |
| HUP0100267A2 (hu) | Helicobacter pylori eredetű nukleinsav- és aminosav-szekvenciák és a megfelelő nukleinsavakat vagy peptideket tartalmazó vakcina-készítmények | |
| WO2001040313A3 (en) | Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof | |
| DK1075523T3 (da) | Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf | |
| NO20081541L (no) | Ny sjo-lus vaksine | |
| WO2004020591A3 (en) | Methods of use for novel human polypeptides encoded by polynucleotides | |
| WO2004087886A3 (en) | Modified adenoviral e1a constructs and methods of use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |